课题基金 / 基金详情

Medical Application of New Technology for imaging second messenger system by Positron Emission Tomography

Medical Application of New Technology for imaging second messenger system by Positron Emission Tomography
正电子发射断层扫描第二信使系统成像新技术的医学应用
批准号:
13557074
负责人:
TATSUO Ido
金额:
$8.7万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

相关文献

中文摘要
翻译
PET第二信使显像在脑功能研究、心肌重塑和肿瘤诊断等方面的临床应用已得到证实。细胞培养和动物模型的基础研究表明,<11>1,2-二酰甘油([^<11>C]DAG)对PLC活性的显像反应和<18>1,2-二酰甘油([^<18>F]FDAG)对PLD活性的显像反应。DAG<11>被用作健康正常受试者和患有各种疾病如中风、帕金森病和阿尔茨海默病的人脑中突触后生物反应的潜在成像示踪剂。心肌<11>梗死(MI)的[^ C]DAG研究表明,该技术可能有助于直观地检测MI后心室重塑过程中PI代谢活化的区域。基于<18>对培养细胞、肿瘤组织和动物模型中PLD活性的响应,将[^ F]FDAG应用于肿瘤检测,并且结果表明[^<18>F]FDAG用作肿瘤生长早期的潜在成像示踪剂。磁共振融合成像计算机程序的开发,将推动动力学分析的临床应用,这一技术用于第二信使系统的医学成像,将是各种医学成像领域的新前沿医学诊断领域。
英文摘要
Clinical applications of second messenger imaging by PET has been demonstrated in the fields of brain function study, myocardial remodeling and tumor diagnosis. Basic study of cell culture and animal model made clear that the imaging by ^<11>C-labeled 1,2-diacylglycerol ([^<11>C]DAG) response to PLC activity and ^<18>F-labeled 1,2-diacylglycerol ([^<18>F]FDAG) response to PLD activity. [^<11>C]DAG is used as potential imaging tracers for postsynaptic biological responses in human brain of healthy normal subjects and with various diseases such as stroke, Parkinson's and Alzheimer's disease. The [^<11>C]DAG study in myocardial infarction(MI) suggested that this technology may be useful for visually detecting regions with activated PI metabolism in the process of ventricular remodeling after MI.[^<18>F]FDAG applied to tumor detection based on the response to PLD activity in cultured cell, tumor tissues and animal models and the results suggested that [^<18>F]FDAG are used as potential imaging tracers for early stage of tumor growth.The simplified PET-MR fusion imaging computer program has been developed to promote clinical application of kinetic analysis.This technology for medical imaging of second messenger systems will be new frontier in various fields of rmedical diagnosis.
期刊论文(44)
专著(0)
科研奖励(0)
会议论文
今堀良夫, 辻野仁, 笹島浩泰, 峯浦一喜, 近藤正樹: "パーキンソン症候群における脳内イノシトールリン脂質代謝のPET測定--運動負荷によるpallidothalamic systemの活性化--"Progress in Medicine. 22・11. 2919-2923 (2002)
Yoshio Imahori、Hitoshi Tsujino、Hiroyasu Sasashima、Kazuki Mineura、Masaki Kondo:“帕金森综合征中脑肌醇磷脂代谢的 PET 测量——运动负荷激活苍白丘脑系统——”医学进展 22. 11. 2919-2923( 2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Imahori, Y, Fujii R, Tujino H, Kimura M, Mineura K.: "Positron emission tomography : measurement of the activity of second messenger systems"Methods. 27. 251-262 (2002)
Imahori, Y, Fujii R, Tujino H, Kimura M, Mineura K.:“正电子发射断层扫描:第二信使系统活性的测量”方法。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kagaya Y, Chida M, Iwhori Y, Fujii R, Namiuchi S, Takeda M, Yamane Y, Otani H, Watanabe J, Fukuchi M, Tezuka F, Ido T, Shirato K.: "Effect of angiotensin converting enzyme inhibition on myocardial phosphoinositide metabolism Visualized with 1-[1-11C]-buty
Kagaya Y、Chida M、Iwhori Y、Fujii R、Namiuchi S、Takeda M、Yamane Y、Otani H、Watanabe J、Fukuchi M、Tezuka F、Ido T、Shirato K.:“血管紧张素转换酶抑制对心肌磷酸肌醇的影响
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 21 条